- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Congress Must Act for Cannabis Patients! Pass Medical Cannabis Legislation NOW! Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2021 State of the States Medical Cannabis in America Cannabis and Cannabis Resin- Critical Review Preparation Document Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- News News
- Join Join
You have an important job to do, if you are attending ASA’s National Medical Cannabis Unity Conference, March 18-22, at the Lowes Madison Hotel in Washington, DC. We will be finalizing a document at the conference that will be submitted to the United Nations Commission on Narcotic Drugs (CND).
The CND meeting in Vienna coincides with the ASA Unity Conference this year. Unity Conference participants will have the opportunity to weigh in on this review document on Sunday March 20th in special stakeholder meetings. Allies within the CND will be calling on the CND, WHO, and UNGASS to use this Critical Review Preparation Document as a stepping-stone to move international cannabis policy forward.
This matters for medical cannabis patients in the United States and all over the world. The UN Single Convention Treaty of 1961 blocks most of the world’s nations from researching or allowing for legal medical cannabis. This treaty is often cited as a reason why the United States cannot make a meaningful change in its national policies towards medical cannabis – despite that fact that forty states have already adopted some kind of law recognizing its medical benefit. Removing this obstacle brings us one step closer to our ultimate goal – safe and legal access for everyone who needs it.
This document was drafted by an advisory group coordinated by ASA staff. Advisory contributors include: Jahan Marcu Ph.D., Steph Sherer, Debbie Churgai, Tjaling Erkelens, Maria de los Angeles Lobos, Ph.D., Ethan Russo, MD, Roy Upton, Mahmoud Elsohly, Ph.D., Ras Bobby Morgan, Pavel Kubu, MD, Sebastien Beguerie, Vasil Harlampiev, Ethan Russo, MD, Pavel Patcha, Jason Schechter, Ph.D., and Phil Robson, Ph.D.
The task for attendees is not to re-write the document or to comment on the authors' writing ability, but to strengthen the existing content. Reviewers are being asked to look for grammatical errors, missing references, or inaccurate/dubious information.
To be a part of this historic process, register today for the ASA Conference today!
Thank you in advance for your dedication in the efforts to improve cannabis policy.
Happy reviewing, and see you in DC!